BRCA1 knockdown was found to effectively increase NAMPT levels in ovarian cancer cells and primary non-BRCA1-mutated cells, suggesting a critical role for NAMPT in BRCA1-related NAD+ synthesis in ovarian cancer [105]. The gene discussed is NAMPT; the disease is ovarian carcinoma.